IMAX Corp does not present a compelling buy opportunity for a beginner, long-term investor at this moment. While the company has positive growth trends in revenue and gross margin, the significant drop in net income and EPS, coupled with neutral technical indicators and insider selling, suggest caution. Analysts' ratings are generally positive, but the lack of strong proprietary trading signals and mixed sentiment from options data further support a hold recommendation.
The MACD histogram is -0.17, indicating bearish momentum, though it is contracting. RSI is neutral at 37.121, and moving averages are converging, suggesting indecision. Key support is at 36.682, and resistance is at 38.416, with the stock currently trading near support levels. No clear bullish or bearish trend is evident.

Analysts have raised price targets recently, with several maintaining Buy ratings.
IMAX is seen as a recession-resistant business model due to its affordability and appeal as a 'staycation' alternative.
Strong Q4 revenue growth (+35.11% YoY) and gross margin improvement (+10.77% YoY).
Insider selling by CEO Richard Gelfond, reducing his holdings by 8.11%.
Net income and EPS saw significant declines (-87.99% and -90.00% YoY, respectively).
Mixed options sentiment with bearish open interest ratios.
Neutral sentiment from hedge funds and insiders.
In Q4 2025, revenue increased by 35.11% YoY to $125.2M, and gross margin improved to 55.96%. However, net income dropped by 87.99% YoY to $637K, and EPS fell by 90.00% YoY to $0.01, indicating profitability challenges despite revenue growth.
Analysts are generally positive, with multiple Buy ratings and price targets raised to $45-$48. However, Goldman Sachs maintains a Neutral rating with a lower price target adjustment to $41.